Thomas G. Frinzi - 16 Jun 2022 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Samuel Gesten as attorney-in-fact for Thomas Frinzi.
Issuer symbol
STAA
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 18:35:00 UTC
Previous filing
25 Jun 2021
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +355 +12% $0.000000 3,279 16 Jun 2022 Direct F1
transaction STAA Common Stock Options Exercise $0 +1,450 +44% $0.000000 4,729 16 Jun 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +2,881 $0.000000 2,881 16 Jun 2022 Common Stock 2,881 $62.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock.
F2 The restricted shares vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date.
F3 The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date.

Remarks:

On June 16, 2022, STAAR Surgical Company granted Mr. Frinzi, a non-employee director, 1450 restricted shares and 2881 options to purchase shares of the Corporation's common stock on his re-election to the Board of Directors.